Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies

James M. Bogenberger, Devora Delman, Nanna Hansen, Riccardo Valdez, Veena Fauble, Ruben A. Mesa, Raoul Tibes

Research output: Contribution to journal › Letter › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies'. Together they form a unique fingerprint.